We found that ErbB2 mammary tumorigenesis was aggravated in p53H/+;ErbB2 mice, compared to p53 null counterparts, indicated by earlier tumor onset and shorter survival (Fig. 2, Table 1,12). This evidence concerns the gene TP53 and neoplasm.